| Maria Peluchi Domingo Pacheco, LPN | |
|
5555 E Arapahoe Rd, Centennial, CO 80122-2312 | |
| (303) 614-1400 | |
| Not Available |
| Full Name | Maria Peluchi Domingo Pacheco |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 5555 E Arapahoe Rd, Centennial, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417285859 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 45757 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Peluchi Domingo Pacheco, LPN 5555 E Arapahoe Rd, Centennial, CO 80122-2312 Ph: (303) 614-1400 | Maria Peluchi Domingo Pacheco, LPN 5555 E Arapahoe Rd, Centennial, CO 80122-2312 Ph: (303) 614-1400 |
News Archive
This is a randomized controlled trial with the aim of decreasing the prevalence of postoperative hypoxemia (deficiency of blood oxygenation) with the early application of oxygen therapy.
Most sexually active teenage girls know relatively little about sexually transmitted diseases (STDs) until it is too late, according to a paper by Carnegie Mellon University researchers that will be published in the January edition of the Journal of Adolescent Health.
Nearly 80 percent of women exercise on a regular basis, yet as much as one-third of these women mistakenly wear their sweat-soaked clothes for as long as an hour following a workout, according to a new survey by Harris Interactive for the Vagisil Women's Health Center(R) (VWHC).
In a project involving the collaboration of several institutes, research scientists of the Johannes Gutenberg University Mainz have succeeded in gaining further insight in the functioning of endogenous mechanisms that protect against the development of Alzheimer's disease.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that starting April 1, 2010 physicians are able to send FNA cell block samples to Rosetta Genomics' CLIA-certified and CAP-accredited laboratory in Philadelphia for analysis using Rosetta's miRview squamous test. FNA is a less invasive method to obtain tumor cells compared with tumor resections or biopsies.
› Verified 5 days ago